SHREE GANESH REMEDIES LTD Share Price
SHREE GANESH REMEDIES LTD Share Price Today
As of 3 Sep 2026, SHREE GANESH REMEDIES LTD share price is ₹684.10. The stock opened at ₹678.00, compared to its previous close of ₹685.65. During today's trading session, SHREE GANESH REMEDIES LTD share price moved in the range of ₹678.00 to ₹699.95, with an average price of ₹688.98 for the day. Looking at its last 52-week, the stock has touched a low of ₹477.05 and a high of ₹700.05. On the performance front, SHREE GANESH REMEDIES LTD share price has increased by 0.19% over the last six months and is up 0.19% on a year-on-year basis.
SHREE GANESH REMEDIES LTD Returns Calculator
About SHREE GANESH REMEDIES LTD
Shree Ganesh Remedies Limited is an India-based company, which is engaged in the business of bulk drug intermediates. The Company's products include intermediates by active pharmaceutical ingredient (API), and fine and specialty chemicals. Its human health API intermediates include antipsychotic, antidepression, oncology, diabetic, and diuretic. Its specialty & fine chemicals include aroma & health industry, agro-industry, polymer industry, and electronics industry. Its veterinary API intermediates include feed additives, antiparasitic, and anti-inflammatory. Its anti-arrhythmic API intermediates include amiodarone intermediates, dronedarone intermediates, and mesalazine intermediates. Its anti-cancer API intermediates include cabozantinib intermediates, gefitinib intermediates, olaparib intermediates, and raloxifene intermediates. Its anti-parasitic API intermediates include flubendazole intermediates, nitazoxanide intermediates, and praziquantel intermediates.
SHREE GANESH REMEDIES LTD Financial Highlights
- Revenue: SHREE GANESH REMEDIES LTD reported revenue of ₹112.32 crore in FY26 vs ₹112.33 crore in FY25. It showed a decrease of 0.01% on a yearly basis.
- Operating Profit: SHREE GANESH REMEDIES LTD reported an operating profit of ₹24.01 crore in FY26 vs ₹31.27 crore in FY25. It showed a decrease of 23.22% on a year-on-year basis.
- Net Profit: SHREE GANESH REMEDIES LTD reported a net profit of ₹17.76 crore in FY26 vs ₹23.07 crore in FY25. It showed a decrease of 23.02% on a yearly basis.
SHREE GANESH REMEDIES LTD Quarterly Result Highlights
- SHREE GANESH REMEDIES LTD reported revenue of ₹15.30 crore in Jun 2026, compared with ₹34.22 crore in Mar 2026, representing a decrease of 55.29% on a quarter-on-quarter (QoQ) basis.
- SHREE GANESH REMEDIES LTD reported an operating profit of ₹1.53 crore in Jun 2026, compared with ₹8.72 crore in Mar 2026, representing a decrease of 82.45% on a quarter-on-quarter (QoQ) basis.
- SHREE GANESH REMEDIES LTD reported a profit of ₹1.12 crore in Jun 2026, compared with ₹6.27 crore in Mar 2026, reflecting a decrease of 82.14% on a QoQ basis.
- The earnings per share (EPS) of SHREE GANESH REMEDIES LTD stood at ₹13.83 during Jun 2026.
| Sep 2025 | 0.01% |
|---|---|
| Dec 2025 | 0.00% |
| Mar 2026 | 0.00% |
| Jun 2026 | 0.00% |
SHREE GANESH REMEDIES LTD Shareholder Returns
SHREE GANESH REMEDIES LTD Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,63,791.00 | 38.28 | 5.55 | 13.74% | 0.61 | 17.33% | 93.24 | 0.83% | 0.48 | 10.90 |
| Divis Laboratories | 2,45,081.00 | 83.79 | 14.62 | 15.32% | 0.00 | 19.56% | 629.49 | 0.32% | 0.55 | 98.19 |
| Torrent Pharmaceuticals | 1,90,351.00 | 88.29 | 22.64 | 25.49% | 1.69 | 13.85% | 222.76 | 0.68% | 0.49 | 58.70 |
| Zydus Lifesciences | 1,14,833.00 | 25.00 | 4.24 | 18.59% | 0.31 | 17.35% | 237.30 | 0.09% | 0.33 | 35.38 |
| Cipla | 1,14,163.00 | 34.02 | 3.32 | 11.27% | 0.00 | 14.95% | 423.36 | 0.92% | 0.45 | 43.52 |
| Laurus Labs | 1,00,660.00 | 92.32 | 18.99 | 16.77% | 0.40 | 16.14% | 97.20 | 0.11% | 0.67 | 13.72 |
| Lupin | 98,431.00 | 17.73 | 4.38 | 23.76% | 0.04 | 24.88% | 659.00 | 0.84% | 0.57 | 129.18 |
| Dr. Reddy's Laboratories | 96,906.30 | 30.44 | 2.55 | 11.07% | 0.18 | 12.54% | 377.95 | 0.69% | 0.41 | 38.68 |
| Mankind Pharma | 98,304.70 | 47.54 | 6.03 | 11.74% | 0.34 | 13.13% | 396.98 | 0.04% | 0.44 | 49.37 |
| Aurobindo Pharma | 95,299.80 | 25.68 | 2.52 | 9.25% | 0.19 | 11.76% | 394.82 | 0.24% | 0.38 | 41.58 |
SHREE GANESH REMEDIES LTD Financials
Income Statement · Consolidated
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2020 |
|---|---|---|---|---|
| Revenue | ₹109.29 | ₹108.60 | ₹125.90 | ₹64.02 |
| Other Income | ₹3.03 | ₹3.73 | ₹3.07 | ₹3.91 |
| Total Revenue | ₹112.32 | ₹112.33 | ₹128.97 | ₹67.93 |
| Total Expenses | ₹88.30 | ₹81.06 | ₹90.81 | ₹54.34 |
| Profit Before Tax | ₹24.01 | ₹31.27 | ₹38.16 | ₹13.59 |
| Tax | ₹6.26 | ₹8.20 | ₹10.05 | ₹3.12 |
| Profit After Tax | ₹17.76 | ₹23.07 | ₹28.11 | ₹10.47 |
| EPS - Basic | ₹13.83 | ₹17.96 | ₹22.34 | ₹11.67 |
| EPS - Diluted | ₹13.83 | ₹17.96 | ₹22.34 | ₹11.67 |
Cash Flow · Consolidated
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2020 |
|---|---|---|---|---|
| Profit before tax | ₹24.01 | ₹31.27 | ₹38.16 | ₹10.47 |
| Income before WC changes | ₹35.64 | ₹42.45 | ₹44.05 | ₹9.93 |
| Change in Assets | -₹11.03 | ₹0.46 | ₹1.41 | -₹9.82 |
| Change in Liabilities | ₹3.96 | -₹2.19 | -₹6.88 | ₹4.48 |
| Change in WC | -₹7.07 | -₹1.73 | -₹5.47 | -₹5.34 |
| Cash flow from Operations | ₹23.74 | ₹30.66 | ₹30.45 | ₹4.59 |
| Cash flow from Investing | -₹9.89 | -₹35.66 | -₹33.01 | -₹2.91 |
| Cash flow from Financing | -₹11.70 | -₹1.09 | ₹9.84 | -₹0.48 |
| Total Cash Flow | ₹2.16 | -₹6.08 | ₹7.28 | ₹1.20 |
| Cash (Start of the year) | ₹9.95 | ₹15.85 | ₹8.66 | ₹1.13 |
| Cash (End of the year) | ₹13.40 | ₹9.95 | ₹15.85 | ₹2.33 |
Balance Sheet · Consolidated
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2020 |
|---|---|---|---|---|
| Non-Current Assets | ₹121.82 | ₹114.37 | ₹100.73 | ₹21.46 |
| Current Assets | ₹85.86 | ₹77.58 | ₹70.20 | ₹33.82 |
| Total Assets | ₹207.69 | ₹191.94 | ₹170.94 | ₹55.28 |
| Current Liabilities | ₹21.69 | ₹16.18 | ₹18.68 | ₹10.38 |
| Net Current Asset | ₹64.17 | ₹61.39 | ₹51.52 | ₹23.44 |
| Non-Current Liabilities | ₹23.03 | ₹30.60 | ₹30.16 | ₹2.65 |
| Equity Capital | ₹162.97 | ₹145.16 | ₹122.10 | ₹42.25 |
| Total Equity & Liabilities | ₹207.69 | ₹191.94 | ₹170.94 | ₹55.28 |
Income Statement · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | ₹109.29 | ₹108.60 | ₹125.90 | ₹91.36 |
| Other Income | ₹3.03 | ₹3.73 | ₹3.07 | ₹0.72 |
| Total Revenue | ₹112.32 | ₹112.33 | ₹128.97 | ₹92.07 |
| Total Expenses | ₹88.30 | ₹81.03 | ₹90.80 | ₹71.84 |
| Profit Before Tax | ₹24.01 | ₹31.30 | ₹38.17 | ₹20.24 |
| Tax | ₹6.24 | ₹8.20 | ₹10.05 | ₹5.05 |
| Profit After Tax | ₹17.77 | ₹23.10 | ₹28.12 | ₹15.18 |
| EPS - Basic | ₹13.84 | ₹17.98 | ₹22.35 | ₹12.54 |
| EPS - Diluted | ₹13.84 | ₹17.98 | ₹22.35 | ₹12.54 |
Cash Flow · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Profit before tax | ₹24.01 | ₹31.30 | ₹38.17 | ₹20.24 |
| Income before WC changes | ₹35.63 | ₹42.45 | ₹44.05 | ₹26.72 |
| Change in Assets | -₹11.03 | ₹0.46 | ₹1.41 | -₹11.23 |
| Change in Liabilities | ₹3.96 | -₹2.19 | -₹6.88 | ₹1.61 |
| Change in WC | -₹7.07 | -₹1.73 | -₹5.47 | -₹9.62 |
| Cash flow from Operations | ₹23.75 | ₹30.66 | ₹30.45 | ₹17.10 |
| Cash flow from Investing | -₹9.89 | -₹35.66 | -₹33.09 | -₹51.09 |
| Cash flow from Financing | -₹11.70 | -₹1.06 | ₹9.85 | ₹38.66 |
| Total Cash Flow | ₹2.17 | -₹6.05 | ₹7.21 | ₹4.67 |
| Cash (Start of the year) | ₹9.90 | ₹15.78 | ₹8.66 | ₹3.88 |
| Cash (End of the year) | ₹13.36 | ₹9.90 | ₹15.78 | ₹8.66 |
Balance Sheet · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Non-Current Assets | ₹121.91 | ₹114.45 | ₹100.82 | ₹75.75 |
| Current Assets | ₹85.83 | ₹77.53 | ₹70.13 | ₹62.22 |
| Total Assets | ₹207.74 | ₹191.98 | ₹170.94 | ₹137.97 |
| Current Liabilities | ₹21.69 | ₹16.18 | ₹18.68 | ₹20.11 |
| Net Current Asset | ₹64.14 | ₹61.35 | ₹51.45 | ₹42.11 |
| Non-Current Liabilities | ₹23.03 | ₹30.60 | ₹30.16 | ₹30.66 |
| Equity Capital | ₹163.02 | ₹145.19 | ₹122.11 | ₹87.20 |
| Total Equity & Liabilities | ₹207.74 | ₹191.98 | ₹170.94 | ₹137.97 |
| 3 Sep | 0L |
|---|---|
| 2 Sep | 0L |
| 1 Sep | 1L |
| 31 Aug | 1L |
| 28 Aug | 0L |
| 27 Aug | 0L |
| Average | 0L |
Popular Stocks
SHREE GANESH REMEDIES LTD Share Price FAQs
What is SHREE GANESH REMEDIES LTD share price today?
SHREE GANESH REMEDIES LTD share price is ₹684.10 as on 03 Sep, 2026, 15:29 IST.
How has the SHREE GANESH REMEDIES LTD share price performed in the past?
In the last 1 year, SHREE GANESH REMEDIES LTD delivered a return of 0.19%. The SHREE GANESH REMEDIES LTD share price hit a high of ₹700.05 and low of ₹477.05.
How much is the Mutual Fund shareholding in SHREE GANESH REMEDIES LTD shares?
The Mutual Fund Shareholding in SHREE GANESH REMEDIES LTD was 0.00% at the end of Jun 2026.
What is the the 52-week high and low of SHREE GANESH REMEDIES LTD shares ?
The 52-week high and low of SHREE GANESH REMEDIES LTD share is ₹700.05 and ₹477.05 as of 03 Sep, 2026.
What is the market cap of SHREE GANESH REMEDIES LTD?
The market capitalisation of SHREE GANESH REMEDIES LTD is ₹878.03 Crores as on 03 Sep, 2026.
What are the stock symbols of SHREE GANESH REMEDIES LTD?
The stock symbol of SHREE GANESH REMEDIES LTD is SGRL on the NSE, 540737 on the BSE, and the ISIN is INE414Y01015.
What was yesterday's closing price of SHREE GANESH REMEDIES LTD shares ?
SHREE GANESH REMEDIES LTD shares closed yesterday at ₹685.65 on NSE & ₹683.95 on BSE
How to buy SHREE GANESH REMEDIES LTD shares?
To buy SHREE GANESH REMEDIES LTD shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy SHREE GANESH REMEDIES LTD shares on Holidays?
No, shares of SHREE GANESH REMEDIES LTD or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell SHREE GANESH REMEDIES LTD shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of SHREE GANESH REMEDIES LTD?
The PE and PB ratio of SHREE GANESH REMEDIES LTD is 56.9 and 5.39 respectively, as on 03 Sep, 2026, 15:29 IST.